Fibromyalgia (FM)BEAMforFMSNCT07361328
Personalized Ultrasonic Brain Stimulation for Fibromyalgia
A study testing Low-intensity ultrasound brain stimulation in people with Fibromyalgia (FM), run by University of Utah at 1 site in United States.
Trial summary
The primary purpose of this research is to evaluate a new kind of noninvasive brain stimulation intervention using the investigational ultrasound device, which might be useful for treating fibromyalgia. The device is for investigational use only and is not yet approved by the FDA for the intended use. Read more about this study
- Who is it for?
- Ages 22 to 70 years
- Conditions the study is for
- Fibromyalgia (FM)
- What is being tested?
- Low-intensity ultrasound brain stimulation
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 50 participants
- Where
- 1 siteUnited States
- Study dates
- 5 Jan 2026to 31 Dec 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Meets American College of Rheumatology criteria for fibromyalgia:
- Generalized pain, defined as pain in at least 4 of 5 regions, is present.
- Widespread pain index (WPI) ≥ 7 and symptom severity scale score (SSS) ≥ 5, or WPI of 4-6 and SSS score ≥ 9.
- Symptoms have been present at a similar level for at least 3 months.
- d.A diagnosis of fibromyalgia is valid irrespective of other diagnoses. A diagnosis of fibromyalgia does not exclude the presence of other clinically important illnesses
- Failure of at least two evidence based medications (i.e., pregabalin, duloxetine, milnacipran) for the treatment of fibromyalgia.
Show all 43Show fewer
- Failure of one or more attempts at physical therapy including:
- Aerobic exercise like walking, cycling, and swimming,
- Water therapy/hydrotherapy with warm water exercises,
- Tai Chi involving slow, controlled movements,
- Yoga,
- Resistance training,
- Bodyweight exercises,
- Pilates,
- Myofascial release therapy applying gentle pressure on trigger points,
- Massage therapy,
- Trigger point therapy targeting specific pain points,
- Joint mobilization,
- Postural retraining to correct body alignment,
- Balance and coordination exercises,
- Feldenkrais method for movement awareness,
- Alexander technique to enhance posture and movement efficiency,
- Transcutaneous Electrical Nerve Stimulation (TENS) for pain relief,
- Heat therapy using hot packs, infrared, or paraffin wax,
- Cold therapy with ice packs or cryotherapy,
- Ultrasound therapy for deep tissue relaxation,
- Biofeedback to control muscle tension and pain response,
- Gentle static stretching for prolonged duration,
- Active dynamic stretching for full range of motion,
- Proprioceptive Neuromuscular Facilitation (PNF) stretching,
- Hydrotherapy pool exercises,
- Ai Chi (water-based Tai Chi),
- Underwater treadmill therapy,
- Graded motor imagery (GMI),
- Mirror therapy to retrain brain-body connections,
- Mindfulness-based stress reduction (MBSR) combining meditation and movement,
- Cognitive-behavioral therapy
- Gaze stabilization techniques for dizziness and disorientation
- Pain score of ≥ 4 on Numerical Rating Scale (NRS-11) at Screening visit.
- Pain score of ≥ 4 on Numerical Rating Scale (NRS-11) at Baseline visit.
- Stated willingness and ability to comply with all study procedures, to receive no additional interventions, and to remain on the same psychiatric treatment regimen (e.g., medication, psychotherapy) beginning at least one (1) month prior to screening and for the duration of the main study period unless a change in treatment is recommended or agreed upon by the site principal investigator.
- For participants of reproductive potential: negative urine or blood pregnancy test at screening; agreement to use a highly effective method of contraception (≤ 1% pregnancy rate) including tubal ligation, vasectomized partner, IUD or IUS (intrauterine device or system), or long-acting contraceptives (LARC).
- Willing and able to provide informed consent
Who cannot join
- Any previous diagnosis of bipolar disorder or schizophrenia-spectrum disorder during the participant's lifetime, according to Diagnostic and Statistical Manual of Mental Disorders, version 5 (DSM-5) criteria.
- Diagnosis of moderate or severe alcohol or other substance use disorder in the past 6 months, according to DSM-5 criteria.
- Diagnosis of obsessive compulsive disorder and/or posttraumatic stress disorder in the past 30 days, according to DSM-5 criteria, and which is unstable in the clinical judgment of the investigator.
- Primary diagnosis of anorexia nervosa, bulimia nervosa, or binge eating disorder in the past 3 months, according to DSM-5 criteria.
- Clinically significant neurodevelopmental, neurocognitive, or personality disorder, according to DSM-5 criteria.
- Moderate-High Risk of Suicide, according to the Columbia-Suicide Severity Rating Scale (C-SSRS) Screen Version - Recent (i.e., answers YES to Question 3 and NO to Question 6 (Moderate Risk), or YES to Question 4, 5, or 6 (High Risk)), or in the clinical judgement of the site principal investigator (PI).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Pain Research Center, University of Utah
Salt Lake City, Utah, 84108
About this study
Official title: Low-intensity Ultrasonic Neuromodulation for Alleviation of Fibromyalgia Symptoms
The primary purpose of this research is to evaluate a new kind of noninvasive brain stimulation intervention using the investigational ultrasound device, which might be useful for treating fibromyalgia. The device is for investigational use only and is not yet approved by the FDA for the intended use.
- Participants will be asked to visit the study center 7 times for in-person assessment and treatment sessions. In addition, participants will be asked to complete an online assessment 7 times. During in-person or online visits:
- Participants will undergo an MRI scan twice during the first and last in-person visit (1 hour each) The second MRI may be optional.
- There will be 6 treatment sessions (45 minutes each) within a 2-week period
- The online assessment occurs (15 minutes each)
- two consecutive days before the first treatment session
- 15 days after the first treatment session
- 22 days after the first treatment session
- 29 days after the first treatment session
- 44 days after the first treatment session
- 60 days after the first treatment session
Read the detailed description
In this study, investigators will recruit 50 people with fibromyalgia. Participants will be asked to go through each of the following steps:
- (In Person or Virtual) Initial visit (screening, medical history, questionnaires, 1 hour) 2. (Virtual) 2 daily pain ratings over two consecutive days (10 min each) 3. (In Person) MRI and 1st treatment session (MRI 1 hour, treatment 45 min, questionnaires 30 min) 4. (In Person) 4 treatment session visits (treatment 45 min each, questionnaires 30 min each) 5. (In Person) MRI (Optional) and last treatment session (MRI 1 hour, treatment 45 min, questionnaires 30 min) 6. (Virtual) questionnaires (20 min) 15 days after the first treatment session 7. (Virtual) questionnaires (20 min) 22 days after the first treatment session 8. (Virtual) questionnaires (20 min) 29 days after the first treatment session 9. (Virtual) questionnaires (20 min) 45 days after the first treatment session 10. (Virtual) questionnaires (20 min) 60 days after the first treatment session
- Initial Visit In-person visit at the Pain Research Center or virtually, participants will be asked to complete a set of questionnaires designed to determine their health status, medical history, fibromyalgia-related symptoms, mood, and ability to do daily chores. Because pregnant women cannot participate in this study, study personnel will ask all female participants who have not achieved menopause to take a pregnancy test in person during this visit. If participants have a virtual visit, the pregnancy test will be done on the next in-person visit. Study personnel will escort participants to the bathroom, where participants will be given a small cup to collect urine. The urine sample will then be tested following the manufacturer's instructions to see if participants are pregnant. Once participants are deemed eligible, they will be assigned to either treatment or sham group. The assignment will be randomly determined at 1:1, meaning participants have 50/50 chance of being in treatment or sham group. If participants are in the Treatment group, they will receive low intensity ultrasound stimulation whereas if participants are in the Sham group, there will be no ultrasound emitted from the device. Study team will then schedule all treatment sessions. There will be a total of 6 treatment sessions within 2 weeks, and they must be separated by at least 24 hours.
- Daily Pain Rating A few days before the MRI and first treatment session, study personnel will ask participants to rate their average and worst pain of the immediate past 24 hours once a day, for two consecutive days. Participants will receive a request on their phone or email to log into the University of Utah RedCap site to record the pain levels.
- MRI and 1st Treatment Session Study personnel will meet participants at the University of Utah, Imaging \& Neuroscience Center (729 Arapeen Drive) for the MRI session. Participants will be asked to remove all metal materials before being escorted into the MRI room. MRI creates images of the brain from magnetic signals. It does not use radiation. The MRI scan involves lying still on a table that moves into a hollow tunnel-like machine. The MRI technician will instruct participants to lie down on the table, stay awake and relaxed, and remain motionless during the scan. Before the MRI scan, participants will be asked to wear a flexible cap on their head to keep their hair down. The cap is a thin, flexible, MRI-compatible cap, similar to a swim cap. Study personnel will take two photos of their head from the side, one with the mock device (similar to the treatment device but without ultrasound) and the other without. Study personnel will provide participants with a surgical mask to wear for protection and privacy. After the pictures are taken, the research study staff will immediately perform the necessary calculations and blur the unmasked parts of their face. The original photographs will then be deleted. The photo-based calculation is needed for investigators to develop the ultrasound method that no longer requires MRI in the future. After the MRI, participants will receive the first ultrasound stimulation session. This will happen either in the private room at the Imaging \& Neuroscience Center or participants will be asked to come to the Pain Research Center (a 6-minute walk or 2-minute drive). Participants will complete a questionnaire and receive the first treatment. Because this is a randomized clinical study, participants will be assigned to receive active, true ultrasound brain stimulation or sham stimulation. The procedure is the same for both. The study uses a device called BEAM. This is an investigational device that looks like an oversized pair of goggles that can be fitted over their forehead. Gel and mineral oil will be applied to each cup that will attach to the temples, and the device will be fastened. Participants will be seated comfortably during the session, which will last about 45 minutes. If participants are assigned to the treatment group, low intensity ultrasound will be emitted whereas if participants are assigned to the sham/placebo group, no ultrasound will be emitted. Once the device is removed, participants will be given a towel to clean the gel and oil. Participants will be asked to complete the questionnaire to rate their pain and mood. After each use, the cups that were attached to the temples will be removed and thoroughly cleaned with soap and warm water.
- 2nd- 5th Treatment Session Participants will receive each treatment session at the Pain Research Center or Imaging \& Neuroscience Center. The procedure is the same as the first treatment session. Additionally, participants will be asked to report any side effects from the treatment.
- 6th Treatment Session and MRI Participants will receive the last (6th) treatment session at the Pain Research Center or Imaging \& Neuroscience Center. The procedure is the same as the previous treatment session. Following this, participants may undergo the 2nd MRI scan at the Imaging \& Neuroscience Center (optional). The procedure will be the same as the first MRI session.
- Online Questionnaires Participants will be asked to complete the symptom questionnaires on
- 15 days after the first treatment session
- 22 days after the first treatment session
- 29 days after the first treatment session
- 45 days after the first treatment session
- 60 days after the first treatment session Participants will receive a request notification on their phone or email to log into the University of Utah RedCap to complete the questionnaires. Each takes about 10-20 minutes.
The study participation will end after the last online questionnaire session.
- Conditions
- Fibromyalgia (FM)
- Being tested
- Low-intensity ultrasound brain stimulation, Sham (No Treatment)
- Keywords
- Fibromyalgia, Ultrasound brain stimulation, Clinical trials, MRI
- Medical subject headings
- Fibromyalgia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Low-intensity ultrasound brain stimulationDevice
Also called BEAM, Ultrasonic
The device is called BEAM, which looks like an oversized pair of goggles that can be fitted over a participant's head. Once fastened, it emits a low-intensity ultrasound wave from your temples that targets a specific area of the brain. The treatment lasts about 45 minutes per session. In this study, participants will undergo a total of 6 sessions within a period of 2 weeks.
Sham (No Treatment)Device
There will be no ultrasound stimulation delivered
| Study group | Role | What they receive |
|---|---|---|
| Ultrasound Group | Experimental | Participants in this group will receive low-intensity ultrasound brain stimulation Receives: Device: Low-intensity ultrasound brain stimulation |
| Sham control | Sham comparator | Participants in this group will undergo the same procedure with the Ultrasound group but do not receive ultrasound stimulation Receives: Device: Sham (No Treatment) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Numerical Rating Scale Pain +15days. 0 (no pain) - 10 (worst pain)
Pain score on the 0-10 scale at Day 15 following the first treatment
Measured: 15 days after the first treatment
Secondary outcomes (6)
Fibromyalgia Impact Questionnaire Revised +15days. 0 (no impact) - 100 (severe impact)
Day15 Fibromyalgia Impact Questionnaire- Revised
Measured: 15 days after the first treatment
Day15 PROMIS29 (Patient-Reported Outcomes Measurement Information System) Interference scale: (20 little/no interference) - 80 (very high interference)
PROMIS-29 (Patient-Reported Outcomes Measurement Information System - Pain interference subscale)
Measured: 15 days after the first treatment
Response Rate 30%
At least 30% reduction in numerical pain score at Day 7
Measured: 7 days after the first treatment
Patient Global Impression of Improvement (1 Very much better - 7 very much worse)
Patient's own assessment of how much symptoms are improved at Day 15
Measured: 15 days after the first treatment
Numerical Rating Scale11 pain score Day 60 (0 No pain - 10 Worst pain)
Numerical pain score at Day 60
Measured: 60 days after the first treatment
Day 15 Columbia suicide Severity Rating Scale (2 No/Low risk - 25 High risk)
Suicidality measured by the Columbia Suicide Severity Rating Scale at Day 15
Measured: 15 days after the first treatment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jan 2026
- Study start5 Jan 2026
- Primary completion31 Dec 2028 (estimated)
- Study completion31 Dec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Fibromyalgia (FM)Studies of the same condition, open and under way.
- More trials run by University of UtahThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Utah
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Akiko Okifuji, University of Utah
- Investigators
- Akiko Okifuji, PhD, Principal investigator, University of Utah
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07361328
- Sponsor's protocol ID
- 00188950
- Acronym
- BEAMforFMS
- Status last verified
- Jan 2026
- First submitted
- 6 Jan 2026
- Last updated
- 23 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Riis TS, Lunt S, Kubanek J. MRI free targeting of deep brain structures based on facial landmarks. Brain Stimul. 2025 Jan-Feb;18(1):131-137. doi: 10.1016/j.brs.2024.12.1478. Epub 2025 Jan 3.
PubMed 39755367Riis TS, Feldman DA, Losser AJ, Okifuji A, Kubanek J. Noninvasive targeted modulation of pain circuits with focused ultrasonic waves. Pain. 2024 Dec 1;165(12):2829-2839. doi: 10.1097/j.pain.0000000000003322. Epub 2024 Jul 30.
PubMed 39073370
Study at a glance
From the registry record, last updated by the sponsor on 23 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Low-intensity Ultrasonic Neuromodulation for Alleviation of Fibromyalgia Symptoms
- ClinicalTrials.gov ID
- NCT07361328
- Acronym / sponsor ID
- BEAMforFMS / 00188950
- Conditions
- Fibromyalgia (FM)
- Keywords
- Fibromyalgia, Ultrasound brain stimulation, Clinical trials, MRI
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- University of UtahUniversity, hospital or other
- Study start
- 5 Jan 2026 (actual)
- Primary completion
- 31 Dec 2028 (estimated)
- Study completion
- 31 Dec 2028 (estimated)
- First posted
- 23 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary purpose of this research is to evaluate a new kind of noninvasive brain stimulation intervention using the investigational ultrasound device, which might be useful for treating fibromyalgia. The device is for investigational use only and is not yet approved by the FDA for the intended use.
- Participants will be asked to visit the study center 7 times for in-person assessment and treatment sessions. In addition, participants will be asked to complete an online assessment 7 times. During in-person or online visits:
- Participants will undergo an MRI scan twice during the first and last in-person visit (1 hour each) The second MRI may be optional.
- There will be 6 treatment sessions (45 minutes each) within a 2-week period
- The online assessment occurs (15 minutes each)
- two consecutive days before the first treatment session
- 15 days after the first treatment session
- 22 days after the first treatment session
- 29 days after the first treatment session
- 44 days after the first treatment session
- 60 days after the first treatment session
Detailed description
In this study, investigators will recruit 50 people with fibromyalgia. Participants will be asked to go through each of the following steps:
- (In Person or Virtual) Initial visit (screening, medical history, questionnaires, 1 hour) 2. (Virtual) 2 daily pain ratings over two consecutive days (10 min each) 3. (In Person) MRI and 1st treatment session (MRI 1 hour, treatment 45 min, questionnaires 30 min) 4. (In Person) 4 treatment session visits (treatment 45 min each, questionnaires 30 min each) 5. (In Person) MRI (Optional) and last treatment session (MRI 1 hour, treatment 45 min, questionnaires 30 min) 6. (Virtual) questionnaires (20 min) 15 days after the first treatment session 7. (Virtual) questionnaires (20 min) 22 days after the first treatment session 8. (Virtual) questionnaires (20 min) 29 days after the first treatment session 9. (Virtual) questionnaires (20 min) 45 days after the first treatment session 10. (Virtual) questionnaires (20 min) 60 days after the first treatment session
- Initial Visit In-person visit at the Pain Research Center or virtually, participants will be asked to complete a set of questionnaires designed to determine their health status, medical history, fibromyalgia-related symptoms, mood, and ability to do daily chores. Because pregnant women cannot participate in this study, study personnel will ask all female participants who have not achieved menopause to take a pregnancy test in person during this visit. If participants have a virtual visit, the pregnancy test will be done on the next in-person visit. Study personnel will escort participants to the bathroom, where participants will be given a small cup to collect urine. The urine sample will then be tested following the manufacturer's instructions to see if participants are pregnant. Once participants are deemed eligible, they will be assigned to either treatment or sham group. The assignment will be randomly determined at 1:1, meaning participants have 50/50 chance of being in treatment or sham group. If participants are in the Treatment group, they will receive low intensity ultrasound stimulation whereas if participants are in the Sham group, there will be no ultrasound emitted from the device. Study team will then schedule all treatment sessions. There will be a total of 6 treatment sessions within 2 weeks, and they must be separated by at least 24 hours.
- Daily Pain Rating A few days before the MRI and first treatment session, study personnel will ask participants to rate their average and worst pain of the immediate past 24 hours once a day, for two consecutive days. Participants will receive a request on their phone or email to log into the University of Utah RedCap site to record the pain levels.
- MRI and 1st Treatment Session Study personnel will meet participants at the University of Utah, Imaging \& Neuroscience Center (729 Arapeen Drive) for the MRI session. Participants will be asked to remove all metal materials before being escorted into the MRI room. MRI creates images of the brain from magnetic signals. It does not use radiation. The MRI scan involves lying still on a table that moves into a hollow tunnel-like machine. The MRI technician will instruct participants to lie down on the table, stay awake and relaxed, and remain motionless during the scan. Before the MRI scan, participants will be asked to wear a flexible cap on their head to keep their hair down. The cap is a thin, flexible, MRI-compatible cap, similar to a swim cap. Study personnel will take two photos of their head from the side, one with the mock device (similar to the treatment device but without ultrasound) and the other without. Study personnel will provide participants with a surgical mask to wear for protection and privacy. After the pictures are taken, the research study staff will immediately perform the necessary calculations and blur the unmasked parts of their face. The original photographs will then be deleted. The photo-based calculation is needed for investigators to develop the ultrasound method that no longer requires MRI in the future. After the MRI, participants will receive the first ultrasound stimulation session. This will happen either in the private room at the Imaging \& Neuroscience Center or participants will be asked to come to the Pain Research Center (a 6-minute walk or 2-minute drive). Participants will complete a questionnaire and receive the first treatment. Because this is a randomized clinical study, participants will be assigned to receive active, true ultrasound brain stimulation or sham stimulation. The procedure is the same for both. The study uses a device called BEAM. This is an investigational device that looks like an oversized pair of goggles that can be fitted over their forehead. Gel and mineral oil will be applied to each cup that will attach to the temples, and the device will be fastened. Participants will be seated comfortably during the session, which will last about 45 minutes. If participants are assigned to the treatment group, low intensity ultrasound will be emitted whereas if participants are assigned to the sham/placebo group, no ultrasound will be emitted. Once the device is removed, participants will be given a towel to clean the gel and oil. Participants will be asked to complete the questionnaire to rate their pain and mood. After each use, the cups that were attached to the temples will be removed and thoroughly cleaned with soap and warm water.
- 2nd- 5th Treatment Session Participants will receive each treatment session at the Pain Research Center or Imaging \& Neuroscience Center. The procedure is the same as the first treatment session. Additionally, participants will be asked to report any side effects from the treatment.
- 6th Treatment Session and MRI Participants will receive the last (6th) treatment session at the Pain Research Center or Imaging \& Neuroscience Center. The procedure is the same as the previous treatment session. Following this, participants may undergo the 2nd MRI scan at the Imaging \& Neuroscience Center (optional). The procedure will be the same as the first MRI session.
- Online Questionnaires Participants will be asked to complete the symptom questionnaires on
- 15 days after the first treatment session
- 22 days after the first treatment session
- 29 days after the first treatment session
- 45 days after the first treatment session
- 60 days after the first treatment session Participants will receive a request notification on their phone or email to log into the University of Utah RedCap to complete the questionnaires. Each takes about 10-20 minutes.
The study participation will end after the last online questionnaire session.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Ultrasound Group | Experimental | Device: Low-intensity ultrasound brain stimulationParticipants in this group will receive low-intensity ultrasound brain stimulation |
| Sham control | Sham comparator | Device: Sham (No Treatment)Participants in this group will undergo the same procedure with the Ultrasound group but do not receive ultrasound stimulation |
Who may qualify
- Ages
- 22 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (43 listed)
- Meets American College of Rheumatology criteria for fibromyalgia:
- Failure of at least two evidence based medications (i.e., pregabalin, duloxetine, milnacipran) for the treatment of fibromyalgia.
- Failure of one or more attempts at physical therapy including:
- Pain score of ≥ 4 on Numerical Rating Scale (NRS-11) at Screening visit.
- Pain score of ≥ 4 on Numerical Rating Scale (NRS-11) at Baseline visit.
Key exclusion criteria (6 listed)
- Any previous diagnosis of bipolar disorder or schizophrenia-spectrum disorder during the participant's lifetime, according to Diagnostic and Statistical Manual of Mental Disorders, version 5 (DSM-5) criteria.
- Diagnosis of moderate or severe alcohol or other substance use disorder in the past 6 months, according to DSM-5 criteria.
- Diagnosis of obsessive compulsive disorder and/or posttraumatic stress disorder in the past 30 days, according to DSM-5 criteria, and which is unstable in the clinical judgment of the investigator.
- Primary diagnosis of anorexia nervosa, bulimia nervosa, or binge eating disorder in the past 3 months, according to DSM-5 criteria.
- Clinically significant neurodevelopmental, neurocognitive, or personality disorder, according to DSM-5 criteria.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Low-intensity ultrasound brain stimulationAlso: BEAM, UltrasonicThe device is called BEAM, which looks like an oversized pair of goggles that can be fitted over a participant's head. Once fastened, it emits a low-intensity ultrasound wave from your temples that targets a specific area of the brain. The treatment lasts about 45 minutes per session. In this study, participants will undergo a total of 6 sessions within a period of 2 weeks. | Device | Ultrasound Group |
| Sham (No Treatment)There will be no ultrasound stimulation delivered | Device | Sham control |
Primary outcome
Numerical Rating Scale Pain +15days. 0 (no pain) - 10 (worst pain)
Time frame: 15 days after the first treatment
Pain score on the 0-10 scale at Day 15 following the first treatment
6 secondary outcomes
Fibromyalgia Impact Questionnaire Revised +15days. 0 (no impact) - 100 (severe impact)
Time frame: 15 days after the first treatment
Day15 PROMIS29 (Patient-Reported Outcomes Measurement Information System) Interference scale: (20 little/no interference) - 80 (very high interference)
Time frame: 15 days after the first treatment
Response Rate 30%
Time frame: 7 days after the first treatment
Patient Global Impression of Improvement (1 Very much better - 7 very much worse)
Time frame: 15 days after the first treatment
Numerical Rating Scale11 pain score Day 60 (0 No pain - 10 Worst pain)
Time frame: 60 days after the first treatment
Day 15 Columbia suicide Severity Rating Scale (2 No/Low risk - 25 High risk)
Time frame: 15 days after the first treatment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jan 2026.
- Results publication: PubMed 39755367Riis TS, Lunt S, Kubanek J. MRI free targeting of deep brain structures based on facial landmarks. Brain Stimul. 2025 Jan-Feb;18(1):131-137. doi: 10.1016/j.brs.2024.12.1478. Epub 2025 Jan 3.
- Results publication: PubMed 39073370Riis TS, Feldman DA, Losser AJ, Okifuji A, Kubanek J. Noninvasive targeted modulation of pain circuits with focused ultrasonic waves. Pain. 2024 Dec 1;165(12):2829-2839. doi: 10.1097/j.pain.0000000000003322. Epub 2024 Jul 30.
- Individual participant dataSharing planned: No
Related trials for Fibromyalgia (FM)
Not yet recruiting
Effects of Adding Vagal Neuromodulation to Manual Therapy in Women With Fibromyalgia
Fibromyalgia (FM) OR Fibromyalgia Syndrome, Manuel Therapy
Recruiting
Feasibility and Effects of Noninvasive Brain Stimulation on Pain Perception in People With Fibromyalgia
Fibromyalgia (FM)
Not yet recruiting
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
ME/CFS, Fibromyalgia (FM)
Not yet recruiting
Multisite Transcutaneous Electrical Nerve Stimulation in Fibromyalgia: A Randomized, Double-Blind, Sham-Controlled Crossover Trial Comparing Two Stimulation Modalities
Fibromyalgia, Fibromyalgia (FM)
Not yet recruiting
Feasibility and Preliminary Effects of an Asynchronous Microlearning Intervention on Fibromyalgia Knowledge Among Primary Health Care Workers
Fibromyalgia, Fibromyalgia (FM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Akiko Okifuji, PhD principal investigator
University of Utah
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Low-intensity ultrasound brain stimulation in people with Fibromyalgia (FM), run by University of Utah at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 43 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 23 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Madison Bunnell, Research Study coordinator (385-209-1070, madison.bunnell@utah.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Numerical Rating Scale Pain +15days. 0 (no pain) - 10 (worst pain) (time frame: 15 days after the first treatment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07361328, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2026.